ClinicalTrials.gov record
A Study to Evaluate the Safety and Efficacy of Topically Applied TV 45070 Ointment in Patients With Postherpetic Neuralgia (PHN)
ClinicalTrials.gov ID: NCT02365636
Public ClinicalTrials.gov record NCT02365636. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Topically Applied TV-45070 (4% and 8% w/w Ointment) in Patients With Postherpetic Neuralgia.
Study identification
- NCT ID
- NCT02365636
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Industry
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Interventions
- TV-45070 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 25, 2015
- Primary completion
- May 8, 2017
- Completion
- May 8, 2017
- Last update posted
- Nov 8, 2021
2015 – 2017
United States locations
- U.S. sites
- 77
- U.S. states
- 28
- U.S. cities
- 68
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 13052 | Birmingham | Alabama | 35213 | — |
| Teva Investigational Site 13086 | Mobile | Alabama | 36608 | — |
| Teva Investigational Site 13514 | Phoenix | Arizona | 85018 | — |
| Teva Investigational Site 13520 | Phoenix | Arizona | 85023 | — |
| Teva Investigational Site 13661 | Little Rock | Arkansas | 72205 | — |
| Teva Investigational Site 13079 | Colton | California | 92324 | — |
| Teva Investigational Site 13331 | Pomona | California | 91767 | — |
| Teva Investigational Site 13341 | Sacramento | California | 95821 | — |
| Teva Investigational Site 13051 | Santa Monica | California | 90404 | — |
| Teva Investigational Site 13055 | Thousand Oaks | California | 91360 | — |
| Teva Investigational Site 13100 | Torrance | California | 90505 | — |
| Teva Investigational Site 13657 | Milford | Connecticut | 06460 | — |
| Teva Investigational Site 13521 | Brandon | Florida | 33511 | — |
| Teva Investigational Site 13085 | Brooksville | Florida | 34601 | — |
| Teva Investigational Site 13057 | Clearwater | Florida | 33761 | — |
| Teva Investigational Site 13084 | Fort Myers | Florida | 33912 | — |
| Teva Investigational Site 13047 | Hialeah | Florida | 33012 | — |
| Teva Investigational Site 13046 | Homestead | Florida | 33030 | — |
| Teva Investigational Site 13098 | Jacksonville | Florida | 32256 | — |
| Teva Investigational Site 13045 | Kissimmee | Florida | 34744 | — |
| Teva Investigational Site 13064 | Miami | Florida | 33126 | — |
| Teva Investigational Site 13338 | Miami | Florida | 33135 | — |
| Teva Investigational Site 13044 | Miami | Florida | 33176 | — |
| Teva Investigational Site 13335 | Miami | Florida | 33183 | — |
| Teva Investigational Site 13522 | Naples | Florida | 34102 | — |
| Teva Investigational Site 13058 | New Port Richey | Florida | 34652 | — |
| Teva Investigational Site 13076 | Oldsmar | Florida | 34677 | — |
| Teva Investigational Site 13073 | Orlando | Florida | 32801 | — |
| Teva Investigational Site 13048 | Orlando | Florida | 32806 | — |
| Teva Investigational Site 13659 | Pembroke Pines | Florida | 33024 | — |
| Teva Investigational Site 13519 | Seminole | Florida | 33708 | — |
| Teva Investigational Site 13056 | St. Petersburg | Florida | 33713 | — |
| Teva Investigational Site 13059 | Tampa | Florida | 33603 | — |
| Teva Investigational Site 13329 | Venice | Florida | 34292 | — |
| Teva Investigational Site 13513 | Virginia Gardens | Florida | 33172 | — |
| Teva Investigational Site 13053 | Atlanta | Georgia | 30331 | — |
| Teva Investigational Site 13063 | Marietta | Georgia | 30060 | — |
| Teva Investigational Site 13091 | Aurora | Illinois | 60506 | — |
| Teva Investigational Site 13072 | Bolingbrook | Illinois | 60490 | — |
| Teva Investigational Site 13062 | Evansville | Indiana | 47714 | — |
| Teva Investigational Site 13093 | Evansville | Indiana | 47725 | — |
| Teva Investigational Site 13074 | Monroe | Louisiana | 71201 | — |
| Teva Investigational Site 13660 | Shreveport | Louisiana | 71105 | — |
| Teva Investigational Site 13094 | Brockton | Massachusetts | 02301 | — |
| Teva Investigational Site 13061 | Detroit | Michigan | 48235 | — |
| Teva Investigational Site 13049 | Farmington Hills | Michigan | 48334 | — |
| Teva Investigational Site 13099 | St Louis | Missouri | 63141 | — |
| Teva Investigational Site 13065 | Las Vegas | Nevada | 89123 | — |
| Teva Investigational Site 13066 | Albuquerque | New Mexico | 87102 | — |
| Teva Investigational Site 13330 | Albuquerque | New Mexico | 87108-5129 | — |
| Teva Investigational Site 13658 | Albany | New York | 12208 | — |
| Teva Investigational Site 13334 | Brooklyn | New York | 11229 | — |
| Teva Investigational Site 13054 | New York | New York | 10128 | — |
| Teva Investigational Site 13083 | North Massapequa | New York | 11758-1802 | — |
| Teva Investigational Site 13060 | Calabash | North Carolina | 28467 | — |
| Teva Investigational Site 13337 | Raleigh | North Carolina | 27612 | — |
| Teva Investigational Site 13082 | Winston-Salem | North Carolina | 27103 | — |
| Teva Investigational Site 13089 | Columbus | Ohio | 43214 | — |
| Teva Investigational Site 13075 | Oklahoma City | Oklahoma | 73103 | — |
| Teva Investigational Site 13328 | Oklahoma City | Oklahoma | 73104 | — |
| Teva Investigational Site 13516 | Oklahoma City | Oklahoma | 73112 | — |
| Teva Investigational Site 13078 | Eugene | Oregon | 97404 | — |
| Teva Investigational Site 13333 | Levittown | Pennsylvania | 19056 | — |
| Teva Investigational Site 13339 | Philadelphia | Pennsylvania | 19146 | — |
| Teva Investigational Site 13327 | Pittsburgh | Pennsylvania | 15206 | — |
| Teva Investigational Site 13332 | Charleston | South Carolina | 29406 | — |
| Teva Investigational Site 13068 | Rapid City | South Dakota | 57702 | — |
| Teva Investigational Site 13095 | Knoxville | Tennessee | 37909 | — |
| Teva Investigational Site 13096 | Memphis | Tennessee | 38119 | — |
| Teva Investigational Site 13070 | Arlington | Texas | 76012 | — |
| Teva Investigational Site 13088 | Austin | Texas | 78731 | — |
| Teva Investigational Site 13340 | McKinney | Texas | 75071 | — |
| Teva Investigational Site 13050 | Plano | Texas | 75093 | — |
| Teva Investigational Site 13518 | Salt Lake City | Utah | 84124 | — |
| Teva Investigational Site 13090 | Norfolk | Virginia | 23507 | — |
| Teva Investigational Site 13081 | Bellevue | Washington | 98007 | — |
| Teva Investigational Site 13336 | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02365636, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 8, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02365636 live on ClinicalTrials.gov.